, 0,15 % 3 1 [In Russian] (n.d.) Available from: Novak, E., Stubbs, S
Variants in genes such as the FTO gene (fat mass and obesity-associated gene) and GLP1R (the receptor that GLP-1 medications target) can influence both weight loss response and baseline metabolic health
The molecule is 4.3 amino acids smaller than EGF but still 68 percent over the passive transepidermal absorption ceiling
Skin bioavailability of dietary vitamin e, carotenoids, polyphenols, vitamin c, zinc and selenium
10.3390/ijms19051537 Int
A Brave New World: Therapeutic Area Deep Dives on Obesity This blog is part of a new series exploring a range of topics in the obesity market, including: market size and scope, impact of payer controls, activity in non-traditional channels, patient behavior, GLP-1 impact, HCP responses, the policy landscape, pharmacy economics, and the outlook for the future of GLP-1